Acute lymphoblastic leukemia in a patient with Prader-Willi syndrome under growth hormone therapy

Pediatrics International

Volumn 47, Issue 3, 2005, Pages 336-337

  Kato, Maiko ^a   Mugishima, Hideo ^a   Chin, Motoaki ^a   Urakami, Tatsuhiko ^a   Harada, Kensuke ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute leukemia; Growth hormone therapy; Prader Willi syndrome

Indexed keywords

CD11B ANTIGEN; CD19 ANTIGEN; CD2 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD24 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; CD4 ANTIGEN; CD7 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; GROWTH HORMONE; HLA DR3 ANTIGEN; SOMATOMEDIN C;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANEMIA; ARTICLE; B CELL LEUKEMIA; BLOOD CELL COUNT; CASE REPORT; CHROMOSOME 15Q; CHROMOSOME DELETION; DRUG WITHDRAWAL; GROWTH HORMONE DEFICIENCY; HUMAN; IMMUNOCYTOCHEMISTRY; INCIDENCE; INFANT; KARYOTYPE 46,XY; LEUKEMIA REMISSION; MALE; MENTAL DEFICIENCY; PANCYTOPENIA; PHYSICAL EXAMINATION; PRADER WILLI SYNDROME; PRIORITY JOURNAL; SCOLIOSIS; SHORT STATURE;

ADOLESCENT; HUMAN GROWTH HORMONE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; PRADER-WILLI SYNDROME; RISK ASSESSMENT;

EID: 20444492382     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-200x.2005.02068.x     Document Type: Article

References (11)

1. Prader A, Labhart A, Willi H. Ein Syndrom von Adipositas, Keinwuchs, Kryptorchismus und Oligophrenie nach myatonieartigem Zustand im Neugeborenealter. J. Schweiz. Med. Wochenschr. 1956; 86: 1260.
2. Carrel AL, Myers SE, Whitman BY, Allen DB. Benefits of long-term GH therapy in Prader-Willi syndrome: A 4-year study. J. Clin. Endocrinol. Metab. 2002; 87: 1581-5.
3. Margaret JT. Growth failure in Prader-Willi syndrome is secondary to growth hormone deficiency. Horm. Res. 1985; 49: 216-20.
4. Davies HD, Leusink GL, McConnell A et al. Myeloid leukemia in Prader-Willi syndrome. J. Pediatr. 2003; 142: 174-8.
5. Nishi Y, Tanaka T, Takano K et al. Recent status in the occurrence of leukemia in growth hormone-treated patient in Japan. J. Clin. Endocrinol. Metab. 1999; 84: 1961-5.
6. Allen DB. Safety of human growth hormone therapy. J. Pediatr. 1996; 128: S8-S13.
7. Watanabe S, Tsunematsu Y, Fujimoto J, Komiyama A. Leukemia in patients treated with growth hormone. Lancet 1998; 21: 1159-60.
8. Hall BD. Leukemia and the Prader-Willi syndrome. Lancet 1985; 1: 46.
9. Allen DB, Rundle AC, Graves DA, Blethen SL. Risk of leukemia in children treated with human growth hormone. J. Pediatr. 1997; 131: S32-S36.
10. Zhang L, Mulvihill JJ, Kinasewitz GT, Scott KV, Bates F, Li S. Duplication 15q in a patient with t(8;21) acute myeloblastic leukemia (M2). Cancer Genet. Cytogenet. 133: 148-51.
11. Heerema NA, Sather HN, Sensel MG et al. Abnormalities of chromosome bands 15q13-15 in childhood acute lymphoblastic leukemia. Cancer 2002; 94: 1102-10.